Contineum Therapeutics (CTNM) Capital Expenditures (2023 - 2026)
Contineum Therapeutics (CTNM) posted Capital Expenditures of $6,000 for Q2 2026, down 86.4% from $44,000 a year earlier and down 98.1% from the prior quarter.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Capital Expenditures (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Contineum Therapeutics was $458,000, up 35.1% year-over-year; for FY2025, it was $231,000, down 55.1% from FY2024.
- In prior years, Contineum Therapeutics' Capital Expenditures was $514,000 in FY2024 (+24.2%) and $414,000 in FY2023.
- The Q2 2026 figure stands as the lowest quarterly Capital Expenditures in data going back to Q1 2023.
- On a year-over-year basis, Capital Expenditures increased in three of the last eight quarters, with growth averaging 64.7%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2026, with growth of 563.8%; the weakest was Q2 2026, with a decline of 86.4%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $312,000 (Q1 2026), $42,000 (Q4 2025) and $98,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Contineum Therapeutics | 313.04 Mn | -615.14 Mn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | 312,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 44,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 166,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Mar 31, 2024 | 147,000.00 |
| Dec 31, 2023 | 309,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | 52,000.00 |
API Access
Contineum Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CTNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CTNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CTNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();